Palisade Bio, Inc. (PALI) vs Sutro Biopharma, Inc. (STRO)
Palisade Bio, Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. Palisade Bio, Inc. and Sutro Biopharma, Inc. are of similar size ($273.6M and $260.5M). Sutro Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Palisade Bio, Inc. grew revenue faster over the last twelve months: 5,492.6% against −56.3%. Sutro Biopharma, Inc. has the higher net margin (−395.3% vs −4,230.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Sutro Biopharma, Inc. leads on 8 and Palisade Bio, Inc. on 7.
Valuation
Profitability
| Metric | PALI | STRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.63% | 100.00% | 65.16% |
| Operating margin | (4,681.99%) | (319.57%) | 0.00% |
| Net margin | (4,230.60%) | (395.25%) | 0.00% |
| Free cash flow margin | (2,409.27%) | (318.63%) | 0.00% |
| Return on equity | (51.37%) | 266.76% | (57.72%) |
| Return on assets | (47.68%) | (79.08%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack